Related Experiment Video
Updated: Sep 3, 2025

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
Cytokine expression by CD163+ monocytes in healthy and Actinobacillus pleuropneumoniae-infected pigs
Rea Jarosova1, Petra Ondrackova2, Lenka Leva2
1Veterinary Research Institute, Brno, Czech Republic; Department of Morphology, Physiology and Animal Genetics, The Faculty of AgriSciences, Mendel University in Brno, Brno, Czech Republic.
Abstract:
Distinct monocyte subpopulations have been previously described in healthy pigs and pigs experimentally infected with Actinobacillus pleuropneumoniae (APP). The CD163+ subpopulation of bone marrow (BM), peripheral blood (PB) and lung monocytes was found to play an important role in the inflammatory process. The inflammation is accompanied by elevation of inflammatory cytokines. The aim of the study was to evaluate the contribution of CD163+ monocytes and macrophages to cytokine production during APP-induced lung inflammation. Cytokine production was assessed by flow cytometry (FC) and quantitative PCR (qPCR) in CD163+ monocytes and by qPCR, immunohistochemistry/fluorescence in lungs and tracheobronchial lymph nodes (TBLN). Despite the systemic inflammatory response after APP infection, BM and PB CD163+ monocytes did not express elevated levels of a wide range of cytokines compared to control pigs. In contrast, significant amounts of IL-1β, IL-6, IL-8 and TNF-α were produced in lung lesions and IL-1β in the TBLN. At the protein level, TNF-α was expressed by both CD163+ monocytes and macrophages in lung lesions, whereas IL-1β, IL-6 and IL-8 expression was found only in CD163+ monocytes; no CD163+ macrophages were found to produce these cytokines. Furthermore, the quantification of CD163+ monocytes expressing the two cytokines IL-1β and IL-8 that were most elevated was performed. In lung lesions, 36.5% IL-1β positive CD163+ monocytes but only 18.3% IL-8 positive CD163+ monocytes were found. In conclusion, PB and BM CD163+ monocytes do not appear to contribute to the elevated cytokine levels in plasma. On the other hand, CD163+ monocytes contribute to inflammatory cytokine expression, especially IL-1β at the site of inflammation during the inflammatory process.
Insights
CD163+ monocytes in pig lungs contribute to inflammation by producing cytokines like IL-1β during Actinobacillus pleuropneumoniae infection. Peripheral blood and bone marrow monocytes do not significantly elevate plasma cytokine levels.
Area of Science:
- Veterinary Immunology
- Swine Pathology
Background:
- Distinct monocyte subpopulations, particularly CD163+, are implicated in inflammatory processes.
- Actinobacillus pleuropneumoniae (APP) infection in pigs triggers inflammation with elevated cytokine levels.
Purpose of the Study:
- To investigate the role of CD163+ monocytes and macrophages in cytokine production during APP-induced lung inflammation.
Main Methods:
- Flow cytometry (FC) and quantitative PCR (qPCR) were used to assess cytokine production in CD163+ monocytes.
- qPCR, immunohistochemistry, and fluorescence were employed on lung tissues and tracheobronchial lymph nodes (TBLN).
Main Results:
- Bone marrow (BM) and peripheral blood (PB) CD163+ monocytes showed no significant cytokine elevation despite systemic inflammation.
- Lung lesions exhibited significant production of IL-1β, IL-6, IL-8, and TNF-α, with IL-1β also found in TBLN.
- In lung lesions, CD163+ monocytes produced IL-1β, IL-6, and IL-8, while both CD163+ monocytes and macrophages produced TNF-α.
Conclusions:
- PB and BM CD163+ monocytes do not contribute to elevated plasma cytokine levels post-APP infection.
- CD163+ monocytes are key producers of inflammatory cytokines, especially IL-1β, at the site of lung inflammation.
More Related Videos
09:00Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment
Published on: June 24, 2020
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020